NPM1 MUTATION
Clinical trials for NPM1 MUTATION explained in plain language.
Never miss a new study
Get alerted when new NPM1 MUTATION trials appear
Sign up with your email to follow new studies for NPM1 MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug trial aims to stop blood Cancer's comeback after transplant
Disease control Recruiting nowThis early-stage study is testing whether adding an experimental drug called ziftomenib to standard care after a bone marrow transplant is safe and can help keep acute myeloid leukemia (AML) from coming back. The study will enroll about 22 adults with specific genetic types of AM…
Matched conditions: NPM1 MUTATION
Phase: PHASE1 • Sponsor: Massachusetts General Hospital • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New hope for Tough-to-Treat leukemia: experimental drug enters human trials
Disease control Recruiting nowThis study is testing whether adding an experimental drug called ziftomenib to standard leukemia treatments is safe and effective. It will involve 420 adults with acute myeloid leukemia (AML) who have specific genetic changes in their cancer cells. The main goals are to find the …
Matched conditions: NPM1 MUTATION
Phase: PHASE1 • Sponsor: Kura Oncology, Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New drug cocktail tested for aggressive leukemia that has returned
Disease control Recruiting nowThis early-stage trial is testing whether adding an experimental drug called ziftomenib to standard leukemia treatments is safe and tolerable for patients. It focuses on adults with acute myeloid leukemia (AML) that has returned or not responded to prior therapy and has specific …
Matched conditions: NPM1 MUTATION
Phase: PHASE1 • Sponsor: Kura Oncology, Inc. • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC